H9N2 avian influenza virus, inactivated vaccine and preparation method thereof
The invention provides an H9N2 avian influenza virus, an inactivated vaccine and a preparation method thereof, and belongs to the field of bioengineering. The preservation registration number of the H9N2 avian influenza virus AH05 strain is CGMCC (China General Microbiological Culture Collection Cen...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | JIE HONGYING ZHU YALU YU YANG BI ZHIXIANG HE JIAHUI ZHAO YANG |
| description | The invention provides an H9N2 avian influenza virus, an inactivated vaccine and a preparation method thereof, and belongs to the field of bioengineering. The preservation registration number of the H9N2 avian influenza virus AH05 strain is CGMCC (China General Microbiological Culture Collection Center) No. 19386. The invention also provides a preparation method of the H9N2 avian influenza virus AH05 strain vaccine. The preparation method comprises the following steps: inactivating AH05 strain virus liquid; uniformly mixing white oil for injection and span-80 to obtain an oil phase solution; uniformly mixing the inactivated AH05 strain virus liquid and Tween-80 to obtain a water phase solution; and mixing the oil phase solution and the water phase solution, and emulsifying to obtain the inactivated vaccine. The invention also provides a Newcastle disease, avian influenza and fowl adenovirus triple inactivated vaccine containing the H9N2 avian influenza virus AH05 strain. The H9N2 avian influenza virus AH05 st |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN113151189A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN113151189A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN113151189A3</originalsourceid><addsrcrecordid>eNqNyrEKwjAQgOEuDqK-w7nrEItgRylKp0zu5Ugu9KC9hOSawafXwQdw-uHj3zZ26OwFsDIKsIR5JXkjVM5rOX0BnXJFJQ8VnWMhQPGQMiXMqBwFFtIpetCJMsWwbzYB50KHX3fN8fl49cOZUhypJHQkpGNvjWnN1Zhbd2__eT7V6TY9</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>H9N2 avian influenza virus, inactivated vaccine and preparation method thereof</title><source>esp@cenet</source><creator>JIE HONGYING ; ZHU YALU ; YU YANG ; BI ZHIXIANG ; HE JIAHUI ; ZHAO YANG</creator><creatorcontrib>JIE HONGYING ; ZHU YALU ; YU YANG ; BI ZHIXIANG ; HE JIAHUI ; ZHAO YANG</creatorcontrib><description>The invention provides an H9N2 avian influenza virus, an inactivated vaccine and a preparation method thereof, and belongs to the field of bioengineering. The preservation registration number of the H9N2 avian influenza virus AH05 strain is CGMCC (China General Microbiological Culture Collection Center) No. 19386. The invention also provides a preparation method of the H9N2 avian influenza virus AH05 strain vaccine. The preparation method comprises the following steps: inactivating AH05 strain virus liquid; uniformly mixing white oil for injection and span-80 to obtain an oil phase solution; uniformly mixing the inactivated AH05 strain virus liquid and Tween-80 to obtain a water phase solution; and mixing the oil phase solution and the water phase solution, and emulsifying to obtain the inactivated vaccine. The invention also provides a Newcastle disease, avian influenza and fowl adenovirus triple inactivated vaccine containing the H9N2 avian influenza virus AH05 strain. The H9N2 avian influenza virus AH05 st</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210723&DB=EPODOC&CC=CN&NR=113151189A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210723&DB=EPODOC&CC=CN&NR=113151189A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JIE HONGYING</creatorcontrib><creatorcontrib>ZHU YALU</creatorcontrib><creatorcontrib>YU YANG</creatorcontrib><creatorcontrib>BI ZHIXIANG</creatorcontrib><creatorcontrib>HE JIAHUI</creatorcontrib><creatorcontrib>ZHAO YANG</creatorcontrib><title>H9N2 avian influenza virus, inactivated vaccine and preparation method thereof</title><description>The invention provides an H9N2 avian influenza virus, an inactivated vaccine and a preparation method thereof, and belongs to the field of bioengineering. The preservation registration number of the H9N2 avian influenza virus AH05 strain is CGMCC (China General Microbiological Culture Collection Center) No. 19386. The invention also provides a preparation method of the H9N2 avian influenza virus AH05 strain vaccine. The preparation method comprises the following steps: inactivating AH05 strain virus liquid; uniformly mixing white oil for injection and span-80 to obtain an oil phase solution; uniformly mixing the inactivated AH05 strain virus liquid and Tween-80 to obtain a water phase solution; and mixing the oil phase solution and the water phase solution, and emulsifying to obtain the inactivated vaccine. The invention also provides a Newcastle disease, avian influenza and fowl adenovirus triple inactivated vaccine containing the H9N2 avian influenza virus AH05 strain. The H9N2 avian influenza virus AH05 st</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQgOEuDqK-w7nrEItgRylKp0zu5Ugu9KC9hOSawafXwQdw-uHj3zZ26OwFsDIKsIR5JXkjVM5rOX0BnXJFJQ8VnWMhQPGQMiXMqBwFFtIpetCJMsWwbzYB50KHX3fN8fl49cOZUhypJHQkpGNvjWnN1Zhbd2__eT7V6TY9</recordid><startdate>20210723</startdate><enddate>20210723</enddate><creator>JIE HONGYING</creator><creator>ZHU YALU</creator><creator>YU YANG</creator><creator>BI ZHIXIANG</creator><creator>HE JIAHUI</creator><creator>ZHAO YANG</creator><scope>EVB</scope></search><sort><creationdate>20210723</creationdate><title>H9N2 avian influenza virus, inactivated vaccine and preparation method thereof</title><author>JIE HONGYING ; ZHU YALU ; YU YANG ; BI ZHIXIANG ; HE JIAHUI ; ZHAO YANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN113151189A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2021</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>JIE HONGYING</creatorcontrib><creatorcontrib>ZHU YALU</creatorcontrib><creatorcontrib>YU YANG</creatorcontrib><creatorcontrib>BI ZHIXIANG</creatorcontrib><creatorcontrib>HE JIAHUI</creatorcontrib><creatorcontrib>ZHAO YANG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JIE HONGYING</au><au>ZHU YALU</au><au>YU YANG</au><au>BI ZHIXIANG</au><au>HE JIAHUI</au><au>ZHAO YANG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>H9N2 avian influenza virus, inactivated vaccine and preparation method thereof</title><date>2021-07-23</date><risdate>2021</risdate><abstract>The invention provides an H9N2 avian influenza virus, an inactivated vaccine and a preparation method thereof, and belongs to the field of bioengineering. The preservation registration number of the H9N2 avian influenza virus AH05 strain is CGMCC (China General Microbiological Culture Collection Center) No. 19386. The invention also provides a preparation method of the H9N2 avian influenza virus AH05 strain vaccine. The preparation method comprises the following steps: inactivating AH05 strain virus liquid; uniformly mixing white oil for injection and span-80 to obtain an oil phase solution; uniformly mixing the inactivated AH05 strain virus liquid and Tween-80 to obtain a water phase solution; and mixing the oil phase solution and the water phase solution, and emulsifying to obtain the inactivated vaccine. The invention also provides a Newcastle disease, avian influenza and fowl adenovirus triple inactivated vaccine containing the H9N2 avian influenza virus AH05 strain. The H9N2 avian influenza virus AH05 st</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN113151189A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | H9N2 avian influenza virus, inactivated vaccine and preparation method thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T17%3A02%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JIE%20HONGYING&rft.date=2021-07-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN113151189A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |